4 commercial payer policies list D57.0. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
4 policies from 2 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of D57.0 |
|---|---|---|
| Brain Natriuretic Peptide Testing | Sep 11, 2023 | Covered |
| Non-myeloablative Hematopoietic Cell Transplantation (Mini-Allograft / Reduced Intensity Conditioning Transplant) | Feb 20, 2024 | Covered |
| Pool Therapy, Aquatic Therapy or Hydrotherapy | Apr 7, 2023 | Covered |
| Policy | Effective | Status of D57.0 |
|---|---|---|
| Adakveo (Crizanlizumab-Tmca) | May 1, 2026 | Covered |